Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04439968 · ClinicalTrials.gov registry record · NA
Neonatal Brain Oxygenation Study
A NA study of Cerebral Hypoxia, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04439968 is a NA study of Cerebral Hypoxia that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04439968, a NA study of Cerebral Hypoxia, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to those without targeted cerebral saturations (Csat) using near-infrared spectroscopy (NIRS). Infants will be randomized to a targeted cerebral saturation monitoring group with visible reading of Csat or to a control group with cerebral saturation monitoring, but with blinded Csat measures. Those in the targeted Csat group will follow a treatment guideline to maintain cerebral oxygenation in the target range. The primary outcome is neurodevelopmental outcome as determined by Bayley III cognitive scale score.
Conditions Studied
Interventions
- OTHER Clinical algorithm
Study Locations (1)
California
- Lucile Packard Children's Hospital Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04439968
The ClinicalTrials.gov registry entry for NCT04439968 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebral Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Clinical algorithm is the first listed.
NCT04439968 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04439968 about?
NCT04439968 is a clinical study titled "Neonatal Brain Oxygenation Study". Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to those without targeted cerebral saturations (Csat) using near-infrared spectroscopy (NIRS). Infants wi...
What is the current status of trial NCT04439968?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-08-10. Estimated completion is 2025-12-31.
What conditions does trial NCT04439968 study?
This clinical trial studies the following conditions: Cerebral Hypoxia.
What interventions are being tested in trial NCT04439968?
The interventions under investigation include: Clinical algorithm (OTHER).
Who is sponsoring clinical trial NCT04439968?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04439968 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.